JS

James Shannon

North America, Pennsylvania, United States, Berwyn

Description

James Shannon, Chairman of the Board: Mannkind Corporation, myTomorrows & Kyowa Kirin (NA).

Investor Profile

James Shannon has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in The Netherlands.
  • Strong thematic focus on Health Care, Medical, Analytics.

Stage Focus

  • Seed (100%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Health Care
  • Medical
  • Analytics
  • Assistive Technology
  • Generative Ai
  • Life Science
  • Machine Learning
  • Pharmaceutical
  • Saas
  • Search Engine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does James Shannon frequently co-invest with?

Keen Venture Partners
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
DFF (Dutch Founders Fund)
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Slimmer AI
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1

Which angels does James Shannon often collaborate with?

David Meeker
North America, Massachusetts, United States, Boston
Shared Deals: 1
JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
DA
Europe, Zuid-Holland, The Netherlands, Leiden
Shared Deals: 1
HG
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
OS
Europe, Zuid-Holland, The Netherlands, The Hague
Shared Deals: 1
DV
Europe, Zuid-Holland, The Netherlands, Leiden
Shared Deals: 2
JT
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
EK
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by James Shannon?

EvidenceHunt

Amsterdam, Noord-Holland, The Netherlands

EvidenceHunt is an AI-powered research platform that streamlines the process of gathering, analyzing and utilizing medical evidence.

AnalyticsAssistive TechnologyGenerative AIHealth CareLife ScienceMachine LearningMedicalPharmaceuticalSaaSSearch Engine
SeedFeb 26, 2025
Amount Raised: $1,259,685
Xinvento

Amsterdam, Noord-Holland, The Netherlands

Xinvento provides a credible alternative treatment for congenital hyperinsulinism.

Health CareMedical
SeedApr 21, 2022

Find More Investors Like James Shannon

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

James Shannon | Pipeseed